Jia Lu Wu
Direktor/Vorstandsmitglied bei Chengdu Aixing Biotech Co. Ltd.
Profil
Jia Lu Wu has worked as a Director at Chengdu Aixing Biotech Co. Ltd.
and as a Member-Supervisory Board at Shanghai Pinnacles Medical Technology Co., Ltd.
Aktive Positionen von Jia Lu Wu
| Unternehmen | Position | Beginn |
|---|---|---|
Chengdu Aixing Biotech Co. Ltd.
 Chengdu Aixing Biotech Co. Ltd. Packaged SoftwareTechnology Services Chengdu Aixing Biotech Co. Ltd. is a company founded in 2013 that develops a point of care testing platform. The company is based in Chengdu, China. | Direktor/Vorstandsmitglied | - |
Shanghai Pinnacles Medical Technology Co., Ltd.
 Shanghai Pinnacles Medical Technology Co., Ltd. Medical SpecialtiesHealth Technology Shanghai Pinnacles Medical Technology Co., Ltd. is a company that focuses on becoming a leading enterprise in the field of smart inspection and precise diagnosis. The company is based in Shanghai, China. The Chinese company aims to provide complete solutions for future inspection needs by combining cross-border technologies and focusing on creating a smart inspection and in vitro diagnostic ecosystem. The company was founded in 2020 by Wei Ding, who has been the CEO since 2020. | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Chengdu Aixing Biotech Co. Ltd.
Chengdu Aixing Biotech Co. Ltd. Packaged SoftwareTechnology Services Chengdu Aixing Biotech Co. Ltd. is a company founded in 2013 that develops a point of care testing platform. The company is based in Chengdu, China. | Technology Services |
Shanghai Pinnacles Medical Technology Co., Ltd.
Shanghai Pinnacles Medical Technology Co., Ltd. Medical SpecialtiesHealth Technology Shanghai Pinnacles Medical Technology Co., Ltd. is a company that focuses on becoming a leading enterprise in the field of smart inspection and precise diagnosis. The company is based in Shanghai, China. The Chinese company aims to provide complete solutions for future inspection needs by combining cross-border technologies and focusing on creating a smart inspection and in vitro diagnostic ecosystem. The company was founded in 2020 by Wei Ding, who has been the CEO since 2020. | Health Technology |
